Viewing nowCombinationNewcoporized 5/80 Milligrams
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
SaeHan Pharmaceutical Co., Ltd.

MFDS item code 202000768 · Approved 2020.02.10 · Insurance code 651300950
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
This medication is used to help control blood pressure in patients with essential hypertension who cannot achieve adequate blood pressure control with monotherapy using amlodipine or valsartan.
The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take this medication at the same time each day (e.g., in the morning), if possible. Before administering this medication, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this medication to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.
Administration of this medication is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication may cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication's components or similar drug classes, women who are pregnant or breastfeeding, individuals with serious kidney or liver diseases, those with a history of angioedema, or patients with severe heart valve diseases or in shock should avoid taking this medication. For patients with insufficient sodium or fluid levels in the body, hypotension may occur, so their condition should be carefully checked before taking this medication, and blood pressure should be monitored closely during treatment. Patients with high potassium levels should have regular blood tests as taking this medication with potassium supplements or potassium-sparing diuretics may increase potassium concentration. Caution is necessary when administering this medication to patients with narrowed renal arteries, kidney transplant recipients, or those with symptoms of angioedema, and treatment should be discontinued immediately if symptoms occur. For patients with heart failure or after myocardial infarction, there may be changes in renal function when taking this medication, requiring regular kidney function tests. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. There may be interactions when taken with certain other medications, so it is essential to inform healthcare personnel of any medications being taken. Elderly patients may take a similar dose to that of a general adult, but they should be monitored closely for side effects. In case of overdose, symptoms like hypotension, dizziness, and arrhythmias may appear, and immediate medical assistance should be sought for appropriate emergency care.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, inguinal edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, hyperkalemia, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitability, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and humidity, so it should be stored in a tightly sealed container. The storage temperature should be kept between 1 degree and 30 degrees Celsius.
Dark yellow round film-coated tablet
For domestic use - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
SaeHan Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.